UCP2 and metabolic dysfunction-associated steatohepatitis: For example, Microsomal triglyceride transfer protein (MTTP) rs1800591 increases the development of NALFD by affecting VLDL secretion, while Uncoupled protein 2 (UCP2) rs695366 reduces the progression of NASH through lipid antioxidant activity [20, 21].